Tobacco Use and Prevalence of Human Papillomavirus in Self-Collected Cervicovaginal Swabs Between 2009 and 2014

HPV and Gynecologic Cancer

Change in Human Papillomavirus Prevalence Among U.S. Women Aged 18-59 Years, 2009-2014

Obstet Gynecol.

Berenson AB, Hirth JM, Chang M

doi: 10.1097/

HPV and Gynecologic Cancer

Performance of human papillomavirus testing on self-collected versus clinician-collected samples for the detection of cervical intraepithelial neoplasia of grade 2 or worse: a randomised, paired screen-positive, non-inferiority trial

Lancet Oncol.

Polman NJ, Ebisch RMF, Heideman DAM, Melchers WJG, Bekkers RLM, Molijn AC, Meijer CJLM, Quint WGV, Snijders PJF, Massuger LFAG, van Kemenade FJ, Berkhof J

doi: 10.1016/S1470-

HPV and Gynecologic Cancer

Safety and acceptability of human papillomavirus testing of self-collected specimens: A methodologic study of the impact of collection devices and HPV assays on sensitivity for cervical cancer and high-grade lesions

J Clin Virol.

Leinonen MK, Schee K, Jonassen CM, Lie AK, Nystrand CF, Rangberg A, Furre IE, Johansson MJ, Tropé A, Sjøborg KD, Castle PE, Nygård M

doi: 10.1016/j.jcv.2017.12.008.

HPV and Gynecologic Cancer

Prevalence and Risk Factors of Human Papillomavirus Infection in 18-Year-Old Women: Baseline Report of a Prospective Study on Human Papillomavirus Vaccine

J Low Genit Tract Dis.

Igidbashian S, Boveri S, Bottari F, Vidal Urbinati A, Preti E, Casadio C, Landoni F, Sideri M, Sandri MT.

doi: 10.1097/

HPV and Gynecologic Cancer

High-grade cervical intraepithelial neoplasia in human papillomavirus self-sampling of screening non-attenders

Br J Cancer.

Lam JUH, Elfström KM, Ejegod DM, Pedersen H, Rygaard C, Rebolj M, Lynge E, Juul KE, Kjær SK, Dillner J, Bonde J

doi: 10.1038/bjc.2017.371.

HPV and Gynecologic Cancer

Use of a 2-Dose Schedule for Human Papillomavirus Vaccination - Updated Recommendations of the Advisory Committee on Immunization Practices

MMWR Morb Mortal Wkly Rep

Meites E, Kempe A, Markowitz LE

doi: 10.15585/mmwr.mm6549a5.

HPV and Gynecologic Cancer

Extended HPV genotyping to compare HPV type-distribution in self and provider-collected samples for cervical cancer screening

Cancer Epidemiol Biomarkers Prev.

Rohner E, Edelman C, Sanusi B, Schmitt JW, Baker A, Chesko K, Faherty B, Gregory SM, Romocki LS, Sivaraman V, Nelson JA, O'Connor S, Hudgens MG, Knittel AK, Rahangdale L, Smith JS

doi: 10.1158/1055-9965.EPI-20-0674.

HPV and Gynecologic Cancer

Incidence and duration of type-specific human papillomavirus infection in high-risk HPV-naïve women: results from the control arm of a phase II HPV-16/18 vaccine trial

BMJ Open.

Ramanakumar AV, Naud P, Roteli-Martins CM, de Carvalho NS, de Borba PC, Teixeira JC, Blatter M, Moscicki AB, Harper DM, Romanowski B, Tyring SK, Ramjattan B, Schuind A, Dubin G, Franco EL; HPV-007 Study Group

doi: 10.1136/

Further Publications Urology

A randomised comparison of different vaginal self-sampling devices and urine for human papillomavirus testing - Predictors 5.1

Cancer Epidemiol Biomarkers Prev

Cadman L, Reuter C, Jitlal M, Kleeman M, Austin J, Hollingworth T, Parberry AL, Ashdown-Barr L, Patel D, Nedjai B, Lorincz AT, Cuzick J

doi: 10.1158/1055-9965.EPI-20-1226

Related content

Change in Human Papillomavirus Prevalence Among U.S. Women Aged 18-59 Years, 2009-2014

Performance of human papillomavirus testing on self-collected versus clinician-collected samples for the detection of cervical intraepithelial neoplasia of grade 2 or worse: a randomised, paired screen-positive, non-inferiority trial

Safety and acceptability of human papillomavirus testing of self-collected specimens: A methodologic study of the impact of collection devices and HPV assays on sensitivity for cervical cancer and high-grade lesions

Prevalence and Risk Factors of Human Papillomavirus Infection in 18-Year-Old Women: Baseline Report of a Prospective Study on Human Papillomavirus Vaccine

High-grade cervical intraepithelial neoplasia in human papillomavirus self-sampling of screening non-attenders

Use of a 2-Dose Schedule for Human Papillomavirus Vaccination - Updated Recommendations of the Advisory Committee on Immunization Practices

Extended HPV genotyping to compare HPV type-distribution in self and provider-collected samples for cervical cancer screening

Incidence and duration of type-specific human papillomavirus infection in high-risk HPV-naïve women: results from the control arm of a phase II HPV-16/18 vaccine trial

A randomised comparison of different vaginal self-sampling devices and urine for human papillomavirus testing - Predictors 5.1